UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 For the transition period from to Commission File Number 001-36052 SIRIUSPOINT LTD. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Point Building 3 Waterloo Lane +1 (441) 542-3300 Pembroke, B ...

• As a percentage of tangible common shareholders' equity4: • Below investment grade / non-rated represents 3% (vs. Q3'23: 7%) • Overall asset duration increased to ~2.8 years up from ~2.7 years at Q3'23 (~1.8 years at Q4'22) Notes: [1] Other includes Strategics, TP Ventures and Legacy & Other Alts. [2] Third Point Enhanced Fund. [3] Excludes short-term investments. [4] Tangible diluted common shareholders' equity attributable to SiriusPoint common shareholders. [5] Total asset leverage calculated as sum of ...

SiriusPoint Ltd. (NYSE:SPNT) Q4 2023 Earnings Conference Call February 21, 2024 8:30 AM ET Company Participants Sarah Singh - VP, IR Scott Egan - CEO Steve Yendall - CFO Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to the SiriusPoint Limited Fourth Quarter and Full Year 2023 Financial Results Conference Call. During today's presentation, all parties will be in listen only mode. As a reminder, this conference call is being recorded and a replay is available through 11 ...

SiriusPoint Ltd. Financial Supplement December 31, 2023 (UNAUDITED) This financial supplement is for informational purposes only. It should be read in conjunction with documents filed with the Securities and Exchange Commission by SiriusPoint Ltd., including the Company's Annual Report on Form 10-K. Point Building Dhruv Gahlaut - Head of Investor Relations and Chief Strategy Officer 3 Waterloo Lane Tel: (044) 20 3772 3111 Pembroke HM 08 Email: investor.relations@siriuspt.com Bermuda Website: www.siriuspt.co ...

SIRIUSPOINT LTD. – A GLOBAL UNDERWRITER 2023 Nine Months and Third Quarter Results Disclaimer Unless the context otherwise indicates or requires, as used in this presentation references to "we," "our," "us," the "Company," and "SiriusPoint" refer to SiriusPoint Ltd. and its directly and indirectly owned subsidiaries, as a combined entity, except where otherwise stated or where it is clear that the terms mean only SiriusPoint Ltd. exclusive of its subsidiaries. We have made rounding adjustments to reach some ...

SiriusPoint Ltd. (NYSE:SPNT) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Dhruv Gahlaut - Head, Investor Relations and Chief Strategy Officer Scott Egan - Chief Executive Officer Steve Yendall - Chief Financial Officer Operator Good morning, ladies and gentlemen and welcome to the SiriusPoint Limited Third Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Dhruv Gahlaut, Head of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ___________________________ FORM 10-Q Point Building 3 Waterloo Lane Pembroke HM 08, Bermuda QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36052 SIRIUSPOINT LTD. (Exact name of registrant as spec ...

SiriusPoint Ltd. (NYSE:SPNT) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Dhruv Gahlaut - Head, IR and Chief Strategy Officer Scott Egan - CEO Steve Yendall - CFO Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to the SiriusPoint Limited Second Quarter 2023 Earnings Call. During today's presentation, all parties will be in a listen-only mode. As a reminder, this conference call is being recorded. I would now like to turn the call over ...

PART I. FINANCIAL INFORMATION [Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) The company reported a significant turnaround in profitability with a net income of **$217.3 million** for the first six months of 2023, reversing a **$269.4 million** loss in the prior year, driven by strong underwriting performance and a substantial positive swing in investment results, leading to total assets growing to **$12.6 billion** and total shareholders' equity increasing to **$2.3 billion** [Consolidated Balance Sheets](index=3&type=section&id=Consolidated%20Balance%20Sheets) As of June 30, 2023, total assets increased to **$12.6 billion** from **$11.0 billion** at December 31, 2022, driven by increases in debt securities and insurance-related receivables, while total liabilities also rose to **$10.4 billion** from **$9.0 billion**, primarily due to higher reinsurance balances payable and unearned premium reserves, with total shareholders' equity growing to **$2.3 billion** from **$2.1 billion** at year-end Consolidated Balance Sheet Highlights (in millions USD) | Balance Sheet Item | June 30, 2023 | December 31, 2022 | | :--- | :--- | :--- | | **Total Investments** | $5,952.8 | $5,653.7 | | **Total Assets** | $12,622.8 | $11,036.3 | | **Total Liabilities** | $10,355.1 | $8,953.7 | | **Total Shareholders' Equity** | $2,267.7 | $2,082.6 | [Consolidated Statements of Income (Loss)](index=4&type=section&id=Consolidated%20Statements%20of%20Income%20(Loss)) The company achieved a net income of **$72.3 million** in Q2 2023, a significant reversal from a net loss of **$56.1 million** in Q2 2022, with the six-month net income reaching **$217.3 million** compared to a **$269.4 million** loss in the prior year, primarily driven by higher net premiums earned and a substantial positive swing in investment results, which went from a **$141.5 million** loss in Q2 2022 to a **$65.8 million** gain in Q2 2023 Key Income Statement Data (in millions USD, except EPS) | Metric | Q2 2023 | Q2 2022 | H1 2023 | H1 2022 | | :--- | :--- | :--- | :--- | :--- | | Net Premiums Earned | $703.8 | $568.8 | $1,299.3 | $1,098.1 | | Total Revenues | $767.9 | $473.1 | $1,453.0 | $834.5 | | Net Investment Gains (Losses) | $65.8 | $(141.5) | $139.6 | $(346.6) | | Net Income (Loss) | $72.3 | $(56.1) | $217.3 | $(269.4) | | Diluted EPS | $0.37 | $(0.38) | $1.14 | $(1.74) | [Consolidated Statements of Cash Flows](index=7&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) For the six months ended June 30, 2023, net cash provided by operating activities was **$206.3 million**, a significant increase from **$45.2 million** in the prior-year period mainly due to higher premium collections, while net cash used in investing activities decreased to **$297.5 million** from **$605.4 million**, and net cash used in financing activities increased to **$51.1 million** primarily due to the settlement of Contingent Value Rights Cash Flow Summary for Six Months Ended June 30 (in millions USD) | Cash Flow Activity | 2023 | 2022 | | :--- | :--- | :--- | | Net cash provided by operating activities | $206.3 | $45.2 | | Net cash used in investing activities | $(297.5) | $(605.4) | | Net cash used in financing activities | $(51.1) | $(11.0) | | **Net decrease in cash** | **$(142.3)** | **$(571.2)** | [Notes to the Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20the%20Consolidated%20Financial%20Statements) Key disclosures in the notes include a significant loss portfolio transfer (LPT) transaction that ceded approximately **$905.6 million** in reserves, resulting in a deferred gain, with segment reporting showing strong performance in the Reinsurance segment, achieving a combined ratio of **72.5%** for H1 2023, and the company recording **$138.4 million** in net favorable prior year loss reserve development for H1 2023, significantly contributing to profitability - On March 2, 2023, the company entered into a loss portfolio transfer (LPT) transaction with Pallas Reinsurance, ceding loss reserves initially estimated at **$1.3 billion**. As of June 30, 2023, this was reduced to **$905.6 million**, and an initial deferred gain of **$21.2 million** was recorded[28](index=28&type=chunk)[29](index=29&type=chunk) - For the six months ended June 30, 2023, the company recorded **$138.4 million** of net favorable prior year loss reserve development, primarily validated by the pricing of the 2023 LPT and continued favorable loss emergence[152](index=152&type=chunk) - For H1 2023, the Reinsurance segment reported underwriting income of **$159.0 million** and a combined ratio of **72.5%**, a significant improvement from **$2.9 million** and **99.6%** in H1 2022[53](index=53&type=chunk)[55](index=55&type=chunk) - For H1 2023, the Insurance & Services segment reported underwriting income of **$30.1 million** and a combined ratio of **95.2%**, compared to **$19.4 million** and **95.8%** in H1 2022[53](index=53&type=chunk)[55](index=55&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=42&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management attributes the strong H1 2023 results to strategic actions including improved underwriting, a significant loss portfolio transfer (LPT), and a de-risked investment portfolio, which improved the Core combined ratio to **78.2%** and the BSCR ratio to **219%** in Q1 2023, enhancing capital flexibility - Management highlights the strategic transformation, focusing on re-underwriting to reduce volatility, de-risking the investment portfolio, and growing the Insurance & Services segment[219](index=219&type=chunk) - The 2023 LPT is expected to result in a net capital increase of over **$150 million** and improve the BSCR ratio by more than **15%** compared to year-end 2022[345](index=345&type=chunk) Key Performance Indicators | Metric | H1 2023 | H1 2022 | | :--- | :--- | :--- | | Combined ratio | 78.2% | 93.4% | | Core income (non-GAAP) | $205.5M | $46.9M | | Book value per common share | $12.59 | $11.56 (at 12/31/22) | | Tangible book value per diluted common share (non-GAAP) | $11.39 | $10.43 (at 12/31/22) | [Consolidated Results of Operations](index=47&type=section&id=Consolidated%20Results%20of%20Operations) The significant improvement in H1 2023 results was driven by a **$211.5 million** increase in total underwriting income and a **$486.2 million** positive swing in investment results compared to H1 2022, stemming from **$138.4 million** in favorable prior year development and lower catastrophe losses, with investment gains driven by higher interest income from the repositioned fixed-income portfolio - H1 2023 underwriting results improved due to favorable prior year loss reserve development of **$138.4 million** (vs **$11.9 million** in H1 2022) and lower catastrophe losses of **$12.9 million** (vs **$23.1 million** in H1 2022)[249](index=249&type=chunk) - Investment results for H1 2023 saw a total gain of **$139.6 million**, a stark contrast to the **$346.6 million** loss in H1 2022, primarily due to higher interest income from the fixed income portfolio and the absence of large losses from related party investment funds[247](index=247&type=chunk)[256](index=256&type=chunk) [Segment Results](index=52&type=section&id=Segment%20Results) The Reinsurance segment was the primary driver of improved profitability, with its H1 2023 combined ratio improving to **72.5%** from **99.6%** in the prior year fueled by significant favorable reserve development, while the Insurance & Services segment saw strong premium growth of **22.8%** in H1 2023, and Corporate results also improved turning to an underwriting income of **$23.5 million** from a loss Reinsurance Segment Underwriting Results (H1) | Metric | 2023 | 2022 | | :--- | :--- | :--- | | Underwriting Income (Loss) | $159.0M | $2.9M | | Combined Ratio | 72.5% | 99.6% | Insurance & Services Segment Underwriting Results (H1) | Metric | 2023 | 2022 | | :--- | :--- | :--- | | Gross Premiums Written | $1,126.7M | $917.4M | | Underwriting Income | $30.1M | $19.4M | | Combined Ratio | 95.2% | 95.8% | [Liquidity and Capital Resources](index=63&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains strong liquidity primarily through its high-quality, short-duration fixed income portfolio and operating cash flows, with its Bermuda Solvency Capital Requirement (BSCR) ratio improving to **219%** in Q1 2023 from **217%** at year-end 2022, and the recent LPT is expected to further improve the BSCR ratio by over **15%**, enhancing capital flexibility - The company's Bermuda Solvency Capital Requirement (BSCR) ratio was **217%** at year-end 2022 and improved to **219%** in Q1 2023[344](index=344&type=chunk) - The 2023 LPT is expected to increase net capital by over **$150 million** and improve the BSCR ratio by more than **15%** from year-end 2022 levels[345](index=345&type=chunk) - As of June 30, 2023, the company had a **$300.0 million** senior unsecured revolving credit facility with no outstanding borrowings[347](index=347&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=67&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company is principally exposed to interest rate risk, foreign currency exchange risk, and price risk in its investment portfolio, where a hypothetical **100 basis point** increase in interest rates would decrease the fair value of its debt securities by approximately **$134.7 million**, risks actively managed through asset-liability matching and derivatives Interest Rate Risk Sensitivity on Debt Securities (as of June 30, 2023) | Assumed Change in Interest Rate | Estimated Change in Fair Value (in millions USD) | | :--- | :--- | | 100 bp decrease | +$127.0 | | 100 bp increase | -$134.7 | | 200 bp increase | -$268.0 | - A hypothetical **10%** increase in the value of the U.S. dollar against the Swedish Krona would result in a pre-tax gain of **$7.1 million** due to the company's net liability position in that currency[383](index=383&type=chunk) [Controls and Procedures](index=69&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were effective as of June 30, 2023, following the implementation of a new general ledger system in Q1 2023 and corresponding internal control adaptations, with no other material changes to internal control over financial reporting occurring during the quarter - The CEO and CFO concluded that disclosure controls and procedures were effective as of June 30, 2023[386](index=386&type=chunk) - A new general ledger and financial reporting system was implemented in Q1 2023, with corresponding modifications to internal controls[387](index=387&type=chunk) PART II. OTHER INFORMATION [Legal Proceedings](index=69&type=section&id=Item%201.%20Legal%20Proceedings) The company is subject to various lawsuits and regulatory actions in the normal course of business, though management believes that no individual litigation or arbitration is likely to have a material adverse effect on its financial condition or operations - The company is involved in claims litigation, disputes over policy interpretations, and other business litigation typical for the insurance industry[390](index=390&type=chunk) - Management believes no current legal proceeding is likely to have a material adverse effect on the company[391](index=391&type=chunk) [Risk Factors](index=70&type=section&id=Item%201A.%20Risk%20Factors) There have been no material changes to the company's risk factors as disclosed in its Annual Report on Form 10-K for the year ended December 31, 2022 - No material changes to risk factors from the 2022 Form 10-K were reported[392](index=392&type=chunk) [Issuer Purchases of Equity Securities](index=70&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company did not repurchase any of its common shares during the three and six months ended June 30, 2023, with approximately **$56.3 million** remaining available for future purchases under the authorized share repurchase program - No common shares were repurchased during the three and six months ended June 30, 2023[394](index=394&type=chunk) - Approximately **$56.3 million** remains authorized for repurchase under the existing program as of June 30, 2023[394](index=394&type=chunk) [Exhibits](index=71&type=section&id=Item%206.%20Exhibits) The report includes several exhibits, such as an employment agreement, an amendment to a credit agreement, the Loss Portfolio Transfer agreements, and required CEO/CFO certifications - Key exhibits filed include the Loss Portfolio Transfer Reinsurance and Retrocession Agreements with Pallas Reinsurance Company Ltd[400](index=400&type=chunk)

SiriusPoint Ltd. (NYSE:SPNT) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Dhruv Gahlaut - Head, IR and Chief Strategy Officer Scott Egan - CEO Steve Yendall - CFO Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to the SiriusPoint Ltd First Quarter 2023 Earnings Conference Call. On today’s presentation, all parties will be in a listen-only mode. As a reminder, this conference call is being recorded. I would now like to turn the call over to ...